Bridgeway Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-102,440
Closed -$26.6K 1500
2023
Q1
$26.6K Hold
102,440
﹤0.01% 1347
2022
Q4
$21.5K Hold
102,440
﹤0.01% 1338
2022
Q3
$26K Hold
102,440
﹤0.01% 1384
2022
Q2
$74K Hold
102,440
﹤0.01% 1256
2022
Q1
$81K Hold
102,440
﹤0.01% 1271
2021
Q4
$102K Hold
102,440
﹤0.01% 1220
2021
Q3
$179K Hold
102,440
﹤0.01% 1210
2021
Q2
$187K Sell
102,440
-100,000
-49% -$183K ﹤0.01% 1269
2021
Q1
$409K Buy
202,440
+92,500
+84% +$187K 0.01% 1148
2020
Q4
$236K Sell
109,940
-22,600
-17% -$48.5K 0.01% 1175
2020
Q3
$358K Buy
132,540
+70,000
+112% +$189K 0.01% 1003
2020
Q2
$246K Buy
+62,540
New +$246K 0.01% 1095
2018
Q4
Sell
-4,275
Closed -$20K 1510
2018
Q3
$20K Hold
4,275
﹤0.01% 1423
2018
Q2
$20K Sell
4,275
-28,219
-87% -$132K ﹤0.01% 1403
2018
Q1
$234K Hold
32,494
﹤0.01% 1251
2017
Q4
$233K Hold
32,494
﹤0.01% 1256
2017
Q3
$270K Hold
32,494
﹤0.01% 1224
2017
Q2
$331K Hold
32,494
﹤0.01% 1188
2017
Q1
$375K Hold
32,494
﹤0.01% 1147
2016
Q4
$408K Hold
32,494
0.01% 1148
2016
Q3
$595K Hold
32,494
0.01% 1011
2016
Q2
$345K Hold
32,494
0.01% 1188
2016
Q1
$614K Hold
32,494
0.01% 962
2015
Q4
$864K Hold
32,494
0.02% 822
2015
Q3
$1.48M Hold
32,494
0.03% 582
2015
Q2
$1.05M Hold
32,494
0.02% 772
2015
Q1
$1.03M Sell
32,494
-4,595
-12% -$146K 0.02% 777
2014
Q4
$1.4M Buy
37,089
+12,500
+51% +$473K 0.03% 656
2014
Q3
$649K Hold
24,589
0.02% 956
2014
Q2
$728K Buy
24,589
+790
+3% +$23.4K 0.02% 915
2014
Q1
$881K Buy
+23,799
New +$881K 0.03% 806